John D. Schuetz

Researchers from St. Jude Children’s Research Hospital discuss the challenges of treating SHH-Medulloblastoma in young children through standard methods such as radiation therapy and SMO inhibitors. They highlight the need for novel therapeutic approaches and explore the potential of an ABC transporter as a new target for treatment.